ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 208.60
-3.60 (-1.70%)
Aug 28, 2026, 4:59 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 46.28 billion as of August 28, 2026. Its market cap has increased by 4.94% in one year.
Market Cap
46.28B
Enterprise Value
44.97B
Revenue
6.83B
Ranking
n/a
PE Ratio
34.21
Stock Price
208.60
ChartMarket Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 46.28B, an increase of 570.00%. That is a compound annual growth rate of 9.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 46.28B | -8.46% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.31T |
| Genmab | 129.37B |
| Coloplast | 103.35B |
| Demant | 60.32B |
| H. Lundbeck | 41.38B |
| Zealand Pharma | 21.59B |
| Ambu A/S | 18.51B |
| Bavarian Nordic | 16.13B |